Multimodal radiomics predicts pathological complete response in breast cancer, suggesting improved treatment personalization.
Compared to single-modal imaging, our multimodal radiomics model provides more comprehensive biomarkers, thereby enabling personalized therapeutic decisions and optimizing NAC regimens to reduce overtreatment.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: